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Background: Allergic skin inflammation such as atopic dermatitis (AD), which is characterized by pruritus and
inflammation, is regulated partly through the activity of regulatory T cells (Tregs). Tregs play key roles in the
immune response by preventing or suppressing the differentiation, proliferation and function of various immune
cells, including CD4+ T cells. Recent studies report that fermentation has a tremendous capacity to transform
chemical structures or create new substances, and the omega-3 polyunsaturated fatty acids (n-3 PUFAs) in fish oil
can reduce inflammation in allergic patients. The beneficial effects of natural fish oil (NFO) have been described in
many diseases, but the mechanism by which fermented fish oil (FFO) modulates the immune system and the
allergic response is poorly understood. In this study, we produced FFO and tested its ability to suppress the allergic
inflammatory response and to activate CD4+CD25+Foxp3+ Tregs.
Results: The ability of FFO and NFO to modulate the immune system was investigated using a mouse model of
AD. Administration of FFO or NFO in the drinking water alleviated the allergic inflammation in the skin, and FFO
was more effective than NFO. FFO treatment did increase the expression of the immune-suppressive cytokines
TGF-β and IL-10. In addition, ingestion of FFO increased Foxp3 expression and the number of CD4+CD25+Foxp3+
Tregs compared with NFO.
Conclusions: These results suggest that the anti-allergic effect of FFO is associated with enrichment of CD4+CD25+
Foxp3+ T cells at the inflamed sites and that FFO may be effective in treating the allergic symptoms of AD.Background
Atopic dermatitis (AD), a chronic inflammatory skin dis-
ease associated with cutaneous hyper-reactivity, affects
approximately 3% of infants, 10 ~ 20% of children and
1~ 3% of adults worldwide [1]. This systemic disorder is
caused by skin barrier dysfunction, severe skin dehydra-
tion, and mutations in the filaggrin gene, which has an
essential role in modulating epidermal homeostasis. The
skin lesions of AD are generally characterized by infiltra-
tion with various inflammatory cells such as mast cells,
basophils, eosinophils and T cells [2-5].
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reproduction in any medium, provided the or(IgE)-receptor complexes at the high-affinity IgE recep-
tor I (FcERI). Of these mediators, histamine is generally
considered as a marker of mast cell degranulation in im-
mediate allergic reaction and is a violent inducer of itch-
ing. Histamine is a characteristic major mediator in mast
cell storage granules and directly triggers type I allergic
responses [6-10].
Thymic stromal lymphopoietin (TSLP) is produced
mainly by epidermal keratinocytes, as well as dermal
fibroblasts and mast cells in the skin lesions of acute
and chronic AD [11]. It strongly promotes dendritic cell
(DC) maturation in the epidermis or can initiate and
regulate the allergic inflammation reaction [12,13]. More-
over, TSLP can stimulate naive T cell to express pro-
inflammatory cytokines (IL-4, -5 and −13) [14].
Regulatory T cells (Tregs) play a key role in various
immune responses, including type 2 helper T cells. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lymph nodes, skin lesions, spleen or peripheral blood
and maintain peripheral immune homeostasis and toler-
ance to allergens. They also prevent or suppress differ-
entiation, proliferation and function of various immune
cells, including CD4+ and CD8+ T cells, through a pro-
cess dependent on cell-cell contact, IL-10, or transform-
ing growth factor (TGF-β) [15-19]. Exhaustion of CD25+
cells can aggravate Th2 cell-mediated inflammation in-
duced by various antigens [20]. Tregs express high CD25
levels at the cell surface and CD25 has been identified as
a marker of Tregs. However, CD25hi expression is re-
garded as an activation marker rather than a normal
marker of Tregs because CD25 expression on Tregs
increases after sensitization with antigens [21]. The ex-
pression of forkhead box protein 3 (Foxp3), which is a
key regulator of Treg development, has been identified
as a specific Treg marker. Foxp3+ T cells can inhibit the
activation or proliferation of various immune cells, in-
cluding Th1, Th2 and Th17 cells [22].
Several previous studies have examined the anti-allergic
effects of fish oil. Fish oil intake can reduce sensitization
to allergens, alleviate the severity of AD, eczema, and
asthma, and down-regulate the expression of IL-1, -4,
and −13 and IFN-γ in serum [23,24]. Fish oil contains
various Omega-3 polyunsaturated fatty acid (n-3 PUFAs),
such as eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) [25]. EPA inhibits the production of pro-
inflammatory cytokines (IL-2, IL-12 and IFN-γ), up-
regulates the expression of anti-inflammatory cytokines
(IL-10), and increases the number of Foxp3+ Tregs [26].
DHA diminishes the proliferation of effector T cells by
increasing mRNA expression of Foxp3, TGF-β and IL-10
from Tregs [27].
Recent studies have investigated the anti-allergic ef-
fects of fermented food products such as yogurt, cheese,
and soybean paste on a variety of allergic reactions, dia-
betes and some cancers [28-30]. Fermentation can trans-
mute the chemical structure of some constituents to
create new substances. The beneficial effects of natural
fish oil (NFO) have been described in many diseases, but
the mechanism by which fermented fish oil (FFO) mod-
ulates the immune system and the allergic response is
poorly understood. In this study, we produced FFO and
found that ingestion of this fish oil resulted in suppres-
sion of various allergic reactions and factors and in-
creased the differentiation of CD4+CD25+Foxp3+ T cells
from CD4+ T cells.
Results
FFO suppresses causative factors in pruritus
To induce experimental AD, mice received an initial
sensitization with 1% dinitrochlorobenzene (DNCB) on
the abdomen, followed by sensitization with 0.5% DNCBon their ears every other day for up to 31 days. Starting
on day 12, the mice were given 100 mg/kg of FFO or
NFO orally every day. On day 32, all mice were sacri-
ficed (Figure 1A). Itching is a critical factor in the main-
tenance of AD symptoms and affects skin edema.
Therefore, we tested whether FFO or NFO has a thera-
peutic effect on pruritus. Mice with experimental AD
were given FFO or NFO (100 mg/kg) every day, and the
mice were painted with hydrocort cream every other
day. We measured the number of scratches in a 10 min
period on days 0, 10 and 31. In the induction group, the
number of scratches increased in a time-dependent
manner. Also, on day 31, FFO and hydrocort cream
treatment significantly decreased (P < 0.05) scratching
behavior (Figure 1B).
IgE is an important therapeutic target for allergy and
AD as it is the major mechanism for activating mast
cells to release histamine [31]. Therefore, we measured
serum IgE and histamine levels in mice with dermatitis
by Enzyme-linked immunosorbent assay (ELISA). The
FFO or NFO-treated group showed significantly decreased
IgE (both P < 0.005) and histamine (each P < 0.001 or
P < 0.005) levels compared with the induction group. In
addition, FFO treatment had a stronger inhibitory effect
than NFO on allergic symptoms (Figure 1C and D).Histological features of ear tissue and TSLP
hyperproduction in DNCB-challenged mice
The skin lesions of AD are characterized by infiltration
of various inflammatory cells such as lymphocytes, gran-
ulocytes, and T cells [32]. Therefore, we tested whether
administration of FFO or NFO alleviates inflammatory
cell infiltration in the ears of mice with experimental
AD. Cutaneous edema as a measure of AD progression
was also measured. Administration of FFO (P < 0.001) or
NFO (P < 0.05) reduced ear thickness; the FFO-treated
group was not appreciably different from the hydrocort
cream treatment group (Figure 2A). The effect of FFO
and NFO treatment on infiltration of inflammatory cells
into the ear tissue was monitored by hematoxylin and
eosin (H&E) staining. The FFO and NFO-treated group
showed significantly decreased epidermal thickness and
inflammatory cell infiltration such as CD3+ cells com-
pared with the induction group (Figure 2B and C).
TSLP produced by epidermal keratinocytes, dermal
fibroblasts and mast cells can activate the maturation
of dendritic cells and regulate allergic inflammation
reactions. Therefore, we measured the expression of
TSLP in AD mice models using IHC and western blot.
The increased TSLP expression was significantly inhib-
ited in the FFO group (Figure 2D and E). Although
both fish oils inhibited various feature of AD mice
models, FFO administration showed stronger inhibitory
Figure 1 FFO suppresses causative factors in pruritus. (A) Mice
were painted with 1% DNCB or vehicle on their abdomen as the
first sensitization (day-7). On day 0, the mice were sensitized with
0.5% DNCB on their ears and were then sensitized with 0.5% DNCB
every other day for up to 31 days. From day 12 until the completion
of the experiment, mice were given FFO or NFO (100 mg/kg) in
their drinking water, daily, and were painted with hydrocort on their
ears every other day. The mice were sacrificed on day 32. (B) Mice
were given 100 mg/kg FFO (●) or NFO (▲) daily and painted with
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infiltration and TSLP hyperproduction.
FFO administration regulates the expression of AD-
associated cytokines and the Foxp3 transcription factor
T cells produce a variety of cytokines. Th1 cells are char-
acterized by the production of inflammatory cytokines
such as IFN-γ and IL-2 and Th2 cells are characterizedρ
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hydrocort (−) every other day. The spontaneous scratching
behaviors of the mice were recorded for 10 min with a digital
camera on days 0, 10 and 31. (C and D) After sacrifice, the histamine
and IgE in mouse serum was measured by ELISA. Data are
representative of 8 mice per group. Values are mean± S.D
(n = 8 mice per group). **, *** compared to mice stimulated with
DNCB alone (induction group). **P< 0.005; *** P< 0.001.by the production of various cytokines including IL-4, -5
and −13. Among these cytokines, IL-4 plays a crucial
role in allergic responses and in the differentiation from
naive T cell to Th2 cell. IL-4 also induces isotype switch-
ing of B cells to produce IgE [33]. We measured whether
FFO affects the expression of pro-inflammatory cyto-
kines in DNCB-induced dermatitis, which is character-
ized as a Th2 inflammatory disorder. The expression of
AD-associated inflammatory factors such as Th2
(IL-4, -13) and Th1 (IFN-γ) cytokines was measured in
the ear tissues of DNCB-stimulated mice by real-time
PCR. In the induction group, the IL-4 level was ex-
tremely elevated. Both FFO and NFO decreased the ex-
pression of IL-4 compared with the induction group
(both P < 0.005); the effect of FFO was not appreciably
different from that of NFO (Figure 3A). Ingestion of
FFO reduced IL-13 (P < 0.001) and IFN-γ (P < 0.001)
mRNA levels compared with the NFO-treated group
(Figure 3B). We also measured the effects of FFO and
NFO on the expression of TGF-β and Foxp3, both of
which induce the proliferation and differentiation of
Tregs. FFO treatment increased the expression of TGF-β
and Foxp3 compared with NFO group (P < 0.001 and
P < 0.05, respectively) (Figure 3C).
FFO attenuates the function of mature Th1/2 cells in
experimental immune disorders
The spleen plays important roles in the active immune
system through the cell-mediated pathway, especially
through the activity of mature T and B cells [34]. There-
fore, we observed the morphologic features of the spleen.
Mice in induction group showed a highly enlarged
spleen. FFO and NFO treatment resulted in a smaller
spleen size with reduced the thickness and length com-
pared to the induction group, and the FFO group had a
smaller spleen than the NFO group (Figure 4A).
We measured whether FFO or NFO suppresses ma-
ture Th1 and Th2 cell functions in the experimental AD
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Figure 2 (See legend on next page.)
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Figure 2 Histological features of ear tissue and TSLP hyperproduction in DNCB-challenged mice. (A) BALB/c mice were sensitized with
DNCB at 2-day intervals for up to 31 days, given 100 mg/kg FFO or NFO daily, and painted with hydrocort every other day, as described in Figure
legend 1. Ear thickness was measured on day 31. (B) Paraffin sections of ear tissues were stained with hematoxylin and eosin (H&E, ×200), and (C)
processed for CD3+ cells and (D) TSLP immunohistochemistry (IHC, ×200). (E) TSLP was measured in ear tissues by western blot. Data are
representative of 8 mice per group. Values are mean± S.D (n = 8 mice per group). *P< 0.05 and ***P< 0.001 compared to mice stimulated with
DNCB alone (induction group).
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3 days. The relative levels of IFN-γ and IL-4 cytokines
were measured by ELISA and the expression of the Th1
T-box-expressed-in-T-cell (T-bet) andTh2GATA-binding
protein 3 (GATA3) transcription factors was measured
by FACS. Spleen cells from mice treated with FFO and
NFO produced significantly less IL-4 and IFN-γ com-
pared with the induction group following stimulation
with anti-CD3/CD28 (Figure 4B). In addition, ingestion
of FFO or NFO decreased T-bet expression from 44.6%
of splenocytes (induction group) to 33.9% (FFO) or 38.3%
(NFO) and decreased GATA3 expression from 28.8%
of splenocytes (induction group) to 18.7% (FFO) or
21.7% (NFO). The FFO group exhibited stronger anti-
inflammatory effects on effector T cell inflammatory fac-
tors than the NFO group (Figure 4C).
FFO administration increases the differentiation of
CD4+CD25+Foxp3+ Treg
The administration of FFO significantly reduced the pro-
gression of experimental AD model by inhibiting various
inflammatory processes. Tregs play a key role in various
immune responses in preventing or suppressing differenti-
ation, proliferation and function of various immune cells
including CD4+ T cells. Therefore, we analyzed whether
administration of FFO or NFO affects the production of
factors related to the generation of Tregs. FFO or NFO
(100 mg/kg) was fed to normal BALB/c mice for 20 days
and all mice were sacrificed on day 21 (Figure 5A). Sple-
nocytes from each group were analyzed without any
stimulation. The administration of FFO did not affect
Foxp3 expression levels and the number of CD25+Foxp3+
Tregs (Figure 5B and C) compared with the normal or
NFO group. However, the FFO group did have significantly
increased expression of Treg-associated anti-inflammatory
factors TGF-β and IL-10 compared with the NFO group
(P < 0.005 or P < 0.01, respectively) (Figure 5D).
The above results suggest that the activity of Tregs
was somehow enhanced or altered by FFO. Therefore,
we analyzed whether administration of FFO or NFO in-
creases the expression of factors related to Treg differ-
entiation during T cell activation. CD4+ T cells were
isolated from splenocytes using CD4+ T cell isolation
beads and were stimulated with anti-CD3 and anti-
CD28 for 3 days. FFO administration increased Foxp3
expression (14.2%) and the number of CD4+CD25+Tregs (16.0%) to levels more than double that in the
NFO group (7.1% and 8.0%, respectively) (Figure 5E
and F). In addition, to confirm that the cells were
genuine Tregs, we analyzed whether administration of
FFO increases the number of CD4+CD25+Foxp3+
Tregs following anti-CD3/anti-CD28 stimulation. FFO
treatment increased the CD4+CD25+Foxp3+ Treg popu-
lation (11.5%) to more than twice that of the NFO group
(5.5%), (Figure 5G).
Discussion
In this study, we fermented natural fish oil and com-
pared the differences between FFO and NFO on the
modulation of the immune system. Administration of
FFO potently induced the generation of CD4+CD25+
Foxp3+ Treg in the spleen compared with NFO treat-
ment. Increased TGF-β and Foxp3 at sites of inflamma-
tion was associated with elevated CD4+CD25+Foxp3+
Treg populations, which can down-regulate the progres-
sion of experimental immune disorders. The ingestion of
FFO generated regulatory T cell populations.
AD mainly appears together with a variety of diseases
such as eczema, asthma and allergic conjunctivitis. The
symptoms of AD include pruritus, peripheral eosino-
philia, epidermal hyperplasia and tissue remodeling,
such as spongiosis.
In the present study, we used the DNCB-induced ex-
perimental AD mouse model to investigate the anti-
inflammatory effect of FFO or NFO. IgE is an important
target in the treatment of allergy, and signaling through
FcERI can induce histamine release from mast cells,
which leads to potent induction of pruritus. Scratching
behavior is a typical consequence of pruritus and aggra-
vates the symptoms of dermatological diseases such as
AD. Therefore, we tested whether FFO or NFO can re-
duce scratching behaviors, serum histamine, IgE hyper-
production and cutaneouse edema. The administration
of FFO or NFO decreased scratching behavior, IgE, his-
tamine levels and edema compared with the induction
group (Figures 1 and 2A). We predicted that the de-
creased IgE and histamine levels after FFO or NFO
treatment would lead to alleviation of pruritus and cu-
taneous edema. H&E staining and IHC of the ear tis-
sue confirmed that ingestion of FFO or NFO alleviated
inflammatory cell infiltration (CD3+ cells) and expres-
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Figure 3 (See legend on next page.)
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Figure 3 FFO administration regulates the expression of AD-associated cytokines and the Foxp3 transcription factor. Mice with
experimental AD were given 100 mg/kg FFO or NFO daily and painted with hydrocort every other day, as described in Figure legend 1. After
sacrifice, ear tissues were isolated and used to measure the mRNA expression of inflammatory cytokines including (A) IL-4, (B) IL-13 and INF-γ,
and (C) TGF-β and Foxp3 by real-time PCR. Data are representative of 8 mice per group. Values are mean± S.D (n = 8 mice per group). *P< 0.05;
** P< 0.005; and *** P< 0.001 compared to mice in induction group (A) or NFO-treated group (B and C).
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stronger inhibitory effects than NFO treatment on
most of these signs of allergic disease.
AD is generally characterized by increased numbers of
activated CD4+ or CD8+ T cells, and enormous numbers
of infiltrating CD4+ T cells in the dermis. In the majority
of patients, AD is primarily associated with a dysfunc-
tion of the body’s immune. In particular, IL-4 plays a
crucial role in allergic responses and the differentiation
of Th2 cells from naïve T cells [35]. Thus, we assessed
whether FFO or NFO has anti-inflammatory effects on
AD model, which is a Th2-mediated immune disorder.
The induction group had extremely elevated IL-4 levels,
which were decreased in the FFO and NFO groups. In
addition, ingestion of FFO markedly reduced IL-13 and
IFN-γ levels and increased the expression of specific
Treg cells markers (TGF-β and Foxp3) compared with
NFO group in DNCB-stimulated atopic dermatitis mice
model (Figure 3). Based on these results, we concluded
that FFO and NFO have potent anti-inflammatory prop-
erties, although the activity of FFO was greater than that
of NFO. Increased expression of TGF-β and Foxp3 by
FFO treatment at the sites of inflammation could reflect
the increased number of Foxp3+ Tregs.
The spleen plays an important role in regulating the
immune system and contains a range of immune cells.
Also, enlared spleen means a splenomegaly by abnor-
mality of immune system function. We observed the
morphologic features of the spleen in AD model. The in-
duction group had markedly enlarged spleens; spleen
size was reduced in the FFO and NFO-treated groups.
Mice in the FFO group had smaller spleens than mice in
the NFO group (Figure 4A). So, FFO reduced enlarged
spleen by alleviating abnormality of immune system
function. Th2 cells produce a variety of cytokines, such
as IL-4, -5 and −13, and preferentially express GATA3,
which is important for Th2 differentiation. Th1 cells
produce IFN-γ and the transcription factor (T-bet) is
critical for the differentiation of Th1 cells [36]. We mea-
sured whether FFO and NFO ingestion regulate the ex-
pression of Th1/Th2 associated factors in experimental
AD model. FFO and NFO decreased IFN-γ and IL-4 levels
and the expression of T-bet and GATA3 (Figure 4B-D).
How does FFO suppress a variety of immune response
in DNCB-stimulated experimental AD? Regulatory T cells
(Tregs) play a key role in various immune responses,including Th2 cell-mediated diseases such as AD, and
prevent or suppress differentiation, proliferation, and
function of various immune cells including CD4+ T cells
in a TGF-β/IL-10/cell contact-dependent manner. Since
all Tregs express CD25 at the cell surface and produce
the Foxp3 transcription factor, these proteins have been
identified as markers of Tregs [37]. We analyzed whether
the administration of FFO affects the expression of fac-
tors related to Tregs differentiation. Although FFO treat-
ment did not increase the Foxp3 level and there was no
difference in the number of CD25+Foxp3+ Tregs com-
pared to the NFO treatment group, the FFO group did
show increased expression of the immune-suppressive
cytokines TGF-β and IL-10 (Figure 5B-D). Interestingly,
FFO administration more than doubled the expression of
TGF-β and Foxp3 at the site of inflammation (Figure 3C).
Therefore, we analyzed whether administration of FFO
and NFO increases the expression of factors related to
Tregs differentiation following stimulation. FFO increased
Foxp3 level (14.2%) and the CD4+CD25+ Tregs popula-
tion (16.0%) more than two-fold compared with NFO in
CD4+T cells stimulated with anti-CD3 and anti-CD28
(Figure 5E and F). In addition, we analyzed whether ad-
ministration of FFO or NFO increases the number of
CD4+CD25+Foxp3+ Tregs following stimulation. FFO
treatment increased the CD4+CD25+Foxp3+ Tregs popu-
lation (11.5%) more than two-fold compared with NFO
treatment (5.5%) (Figure 5G). As a result, ingestion of
FFO significantly increased Foxp3 expression and in-
duced the differentiation of CD4+CD25+Foxp3+ Tregs
from CD4+ Tcells. These results indicate that FFO is more
effective than NFO in disease suppression and inducing
CD4+CD25+Foxp3+ Tregs.
Why does FFO show more potent anti-allergic effects
than NFO? Fish oil contains a variety of substances, such
as stearic acid, eicosatrienoic acid, linolenic acid, EPA
and DHA [38]. Especially, EPA and DHA are mainly ef-
fective for skin inflammation. Several previous studies
have suggested that EPA and DHA diet alleviate ear
oedema and inhibit the production of pro-inflammatory
factors (IκB, MAPKs, TNF-α, IL-6 and COX-2) in ex-
perimental skin inflammation models [39-41]. FFO con-
tains more than double the concentration of EPA and
DHA (Table 1). In addition, fermentation would trans-
mute the chemical structure of some constituents of
fish oil to create new substances, which have immune-
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Figure 4 FFO attenuates mature Th1/2 cell functions in experimental atopic dermatitis. (A) Mice were stimulated with DNCB for up to
31 days at 2-day intervals, given 100 mg/kg FFO or NFO every day, and were painted with hydrocort every other day, as described in Figure
legend 1. After sacrifice, the spleen was isolated and photographed to record the morphologic alteration. (B) Splenocytes were isolated from
mice in each experimental group and 1.0 × 106 cells/mL were stimulated with anti-CD3 (1 μg/mL) and anti-CD28 (0.5 μg/mL) for 3 days. Mouse
IL-4 and IFN-γ were measured in the culture supernatant by ELISA. (C) Cells were permeabilized with T-bet fixation/permeabilization buffer and
stained with anti-T-bet-Alexa Fluor® 488 and anti-GATA3-PE and analyzed by FACS. Data are representative of 8 mice per group. The
measurements were made in triplicate and are shown as mean± S.D (n = 8 mice per group). (B) *P< 0.05; **P< 0.005; and *** P< 0.001 compared
to mice sensitized with DNCB alone (induction group).
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CD4+CD25+Foxp3+ Tregs.
In summary, FFO had stronger inhibitory effects on
various experimental AD symptoms than NFO by up-regulating the generation of Tregs. It is not yet clear
why FFO has stronger immunomodulatory effects than
NFO. So we are currently trying to identify the interrela-
tionships between FFO, EPA, DHA and Tregs. Our
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Figure 5 FFO administration promotes the differentiation of
CD4+CD25+Foxp3+ Treg. (A) Naïve mice were given 100 mg/kg
FFO or NFO in their drinking water, daily, for 20 days. The mice were
sacrificed on day 32. (B) Splenocytes were isolated from the spleens
of each group and 1.0 × 106 cells/mL were permeabilized with Foxp3
fixation/permeabilization buffer and stained with anti-Foxp3-FITC
and (C) anti-CD25-PE and anti-Foxp3-FITC. The Foxp3 and
CD25+Foxp3+ Treg population was analyzed by FACS. Data are from
five mice per group. (D) The expression of TGF-β and IL-10 mRNA in
the spleen was measured by real-time PCR. (E) Splenocytes (1.0 × 106
cells/mL) were stimulated with anti-CD3 (1 μg/mL) and anti-CD28
(0.5 μg/mL). After 3 days, the cells were permeabilized with Foxp3
fixation/permeabilization buffer and stained with anti-Foxp3-FITC. (F)
The cells from panel (E) were stained with anti-CD4-FITC and anti-
CD25-PE. (G) CD4+ T cells were isolated from splenocytes using CD4+
T cell isolation beads. The CD4+ T cells (1.0 × 106 cells/mL) were
stimulated with anti-CD3 (1 μg/mL) and anti-CD28 (0.5 μg/mL) for
3 days, after which they were permeabilized with Foxp3 fixation/
permeabilization buffer and stained with anti-Foxp3-FITC and anti-
CD25-PE. All data (panels A-G except for D) are from FACS analysis.
Data are representative of five mice per group. In panel (D), the
values are mean± S.D (n = 5 mice per group). *P< 0.05; and
**P< 0.005 compared to mice treated with NFO.
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associated with the enrichment of CD4+CD25+Foxp3+
Treg at the site of inflammation and that fermented fish
oil may be an effective treatment for the allergic symp-
toms of AD.
Conclusions
In conclusion, we produced fermented fish oil and tested
its ability to suppress the allergic inflammatory response
and to activate CD4+CD25+Foxp3+ T cells. Administra-
tion of FFO alleviated the allergic inflammation, and did
increase the expression of the immune-suppressive cyto-
kines TGF-β and IL-10. Increased TGF-β and Foxp3 by
FFO was associated with regulatory T cell populations,
which can down-regulate the progression of experi-
mental immune disorders. The ingestion of FFO up-
regulated the generation of CD4+CD25+Foxp3+ Tregs. It
is not yet clear why FFO has strong immune-modulatory
effects. So, we are currently trying to identify the interre-
lationships between omega-3 fatty acids and Tregs.
These results suggest that the anti-allergic effect of FFO
is associated with enrichment of CD4+CD25+Foxp3+ T
cells at the inflamed sites and that FFO may be effective
in treating the allergic symptoms of AD.
Methods
Experimental animals
BALB/c mice (female, 7-weeks-old) were purchased
from Orient Bio (Korea) and were maintained for 1 week
before the start of any experiments. The mice were
housed in the animal facility of Jeju National University
under controlled temperature (23 ± 1°C), humidity (60 ±
10%), and light (lights on from 08:00 to 20:00 hours) and
Table 1 Fatty acid composition of natural fish oil and
fermented fish oil




Myristic acid C14:0 3.430 2.954
Stearic acid C18:0 3.417 2.992
Eicosatrienoc acid C20:3 0.523 0.497
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were approved by the Animal Care and Use Committee
at Jeju National University.
Fermentation of fish oil
FFO was provided by Fermentec Inc. (Jeju, Korea). Pul-
verized fish by-product was mixed with water, raw sugar,
Lactobacillus plantarum and Saccharomyces cerevisiae
under anaerobic fermentation conditions. After 15 days,
hexane was added to the fermented fish liquid. FFO was
separated from the hexane extract by rotary evaporation.
Fatty acid composition of natural fish oil and fermented
fish oil
The fatty acid compositions of NFO and FFO were ana-
lyzed by the Feeds & Foods Nutrition Research Center
(Pukyong National University, Korea) using the gas
chromatography (Table 1).
Determination of optimal dosage of FFO
To determine the optimal dose of FFO, we tested the
anti-allergic effect of FFO in the compound 48/80
(Sigma-Aldrich)-induced pruritus mouse model. FFO
(20, 50 or 100 mg/kg) was orally administered 1 h before
the subcutaneous injection of compound 48/80 (5 mg/kg).
One hour after injection of compound 48/80, the amounts
of IgE and histamine in the serum were measured. A dose
of 100 mg/kg of FFO reduced serum IgE and histamine
levels in this model.
DNCB application to induce experimental AD
Mice were divided into five groups (normal, induction,
positive control, NFO and FFO; n = 8 mice per group).
Mice were painted with 300 μL of 1% DNCB or vehicle
on their abdomen as the first sensitization (day-7). On
day 0, the mice were sensitized with 200 μL of 0.5%
DNCB on their ears and were then sensitized with 200
μL of 0.5% DNCB every other day for up to 31 days.
From day 12 until the completion of the experiment,
mice were given FFO or NFO (100 mg/kg) in theirdrinking water, daily, and were painted with hydrocort
cream (Green Cross, Korea) containing 2 mg/g hydro-
cortisone valerate as positive control on their ears every
other day. The mice were sacrificed on day 32.
Scratching behavior, macroscopic edema and histological
evaluation
In the experimental AD mouse model, DNCB stimula-
tion elicited scratching of the ears with the hind paws
around the painted site. The mice in each group were
placed in an observation chamber and scratching beha-
viors were videotaped for 10 min. The number of
scratching behaviors during this period was counted. Ear
thickness was measured using a Digital Thickness Gauge
(Mitutoyo). Ear tissues were fixed with 10% formalin
and embedded in paraffin. Paraffin sections (3 μm each)
were stained with H&E.
Immunohistochemistry (IHC) assay for detection of CD3+
cells and TSLP in ear tissue
To analyze the expression of TSLP in each ear, paraffin
sections (3 μm, each) of ear tissue were prepared. IHC
was performed with rabbit anti-CD3 and rabbit anti-
TSLP (Novus Biologicals) and a rabbit-specific HRP/
DAB detection IHC kit (Abcam) according to the manu-
facturer’s instructions.
Western blot for detection of TSLP in ear tissue
Total protein was isolated from ear tissue using lysis
buffer and the protein concentration of each sample was
quantified by the bradford assay. The proteins were elec-
troblotted onto a polyvinylidene difluoride (PVDF)
membrane using an iBlot gel transfer device (Invitrogen).
The membrane was incubation with rabbit anti-TSLP
(Novus Biologicals). After washing, the membrane was
incubated with horseradish peroxidase (HRP)-conjugated
anti-rabbit IgG. The blot was visualized with a western
blot detection system (iNtRON Biotechnology) accord-
ing to the manufacturer’s instructions.
Elisa
IgE (Biolegend, San Diego, CA) and histamine (Labor
Diagnostika Nord, Nordhorn, Germany) in mouse serum
and IL-4 and IFN-γ (R&D Systems, St. Louis, MO) in
the supernatant of cultured cells were measured using
ELISA kits according to the manufacturer’s instructions.
Splenocyte culture in BALB/c mouse
Mice from each group were sacrificed by cervical dis-
location and their spleens were removed aseptically. To
obtain single-cell suspensions, red blood cells were
removed using red blood cell lysis buffer. After washing,
splenocytes (1.0 × 106 cells/mL) were incubated in the
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CD28 (0.5 μg/mL) (eBioscience) for 3 days. Following in-
cubation, the supernatants were collected to determine
levels of IL-4 and IFN-γ and the cells were immediately
analyzed by flow cytometric analysis (BD Biosciences).
Isolation of CD4+ T cells from splenocytes
Isolation of CD4+ T cells from splenocytes used a
purified anti-mouse CD4 (eBioscience) that had been la-
beled using the DSB-X™ Biotin Protein Labeling Kit
(Invitrogen) according to the manufacturer’s instruc-
tions. Briefly, cells were incubated with DSB-X labeled
antibody for 10 min. The bead-bound cells were incu-
bated for 10 min in FlowComp release buffer. The
supernatant containing the bead-free cells was trans-
ferred to a new tube and the cell pellet was resuspended
in RPMI Medium 1640 (Gibco).
Flow cytometric analysis (FACS)
To analyze Foxp3 expression, cells were permeabilized
with the Foxp3 fixation/permeabilization kit (BD Bios-
ciences) and stained with anti-Foxp3-FITC (eBioscience)
according to the manufacturer’s instructions. Briefly, to
block mouse Fc receptors, the cell suspension was incu-
bated with CD16/CD32 (BD Biosciences) for 15 min, fol-
lowed by incubation in fixation/permeabilization buffer
for 20 min and anti-Foxp3-FITC for 30 min. To measure
the differentiation of CD4+CD25+ T cells, CD4+ T cells
were stained with anti-CD4-FITC (eBioscience) and anti-
CD25-PE (eBioscience). To block mouse Fc receptors,
the cell suspension was incubated with CD16/CD32 (BD
Biosciences) for 15 min, followed by incubation with
anti-CD4-FITC for 30 min and anti-CD25-PE for 30 min.
Extraction of total RNA and real-time PCR
Total RNA was isolated using TRI reagent (Molecular
Research Center) according to the manufacturer’s
instructions. Reverse transcription was performed using
a First-Strand cDNA Synthesis kit (Promega). The real-
time quantitative PCR was performed with TaqMan®
Universial Master Mix II or Brilliant III Ultra-Fast SYBR®
Green QPCR Master Mix (Agilent Technologies) with a
StepOnePlus™ Real-Time PCR (Applied Biosystems). Real-
time PCR results were analyzed using the StepOne™ soft-
ware, which measures the amplification of the target and
the endogenous control in samples and in a reference
sample. The data were normalized using the endogenous
control. The mRNA levels were normalized to the ex-




5’-GTCAGGGAATCCAGGG CTAC-3’), mIFN-γ (forward:
5’-TCAAGTGGCATAGATGTGGAAGAA-3’; reverse: 5’-TGGC TCTGCAGGATTTTCATG-3’), mTGF-β (for-
ward: 5’-GAAGGCAGAGTTCAGGGTCTT-3’; reverse:
5’-GGTTCCTGTCTTTGTGGTGAA-3’), mIL-10 (for-
ward: 5’-ATAACTGCACCCAC TTCCCA-3’; reverse:
TCATTT-CCGATAAGGCTTGG-3’), and mFoxp3 (for-
ward: 5’-CCCATCCC CAGGAGTCTTG-3’; reverse: 5’-
CCATGA-CTAGGGGCACTGTA-3’)
Statistical analysis
Quantity One version 4.2.1 and Image-Pro plus version
4.5 software were used to transform images into numer-
ical values. Student’s t-test and two-way analysis of vari-
ance were used to determine the statistical significance
of differences between experimental and induction
groups. Data are shown as mean ± standard deviation.
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